Although limited, prior reports indicate that a subset of the predicted targets (e.g. ATM, UBE2I, APEX, ADAM1, BUB1B, PAK2, PRMT5) are involved in ACC pathogenesis (Supplementary Table 6), supporting the validity of our predictive discovery pipeline. The gene discussed is PAK2; the disease is adrenal cortex carcinoma.